Divi's LaboratoriesNSE:DIVISLAB -0.59%94 Days Inventory is 322.43 as of Mar. 2026, which is 7% above its 10-year median of 302.56. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 94/100 and a GF Value™ of ₹6,732.51 (Fairly Valued). The stock has 5 warning signs investors should review. Among 916 Drug Manufacturers companies, Divi's Laboratories ranks worse than 85.92% on this metric.
The historical rank and industry rank for Divi's Laboratories's Days Inventory or its related term are showing as below:
NSE:DIVISLAB'
s Days Inventory Range Over the Past 10 Years
Min: 287.94 Med: 302.56 Max: 345.24
Current: 315.77
During the past 13 years, Divi's Laboratories's highest Days Inventory was 345.24. The lowest was 287.94. And the median was 302.56.
NSE:DIVISLAB's Days Inventory is ranked worse than 85.92% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NSE:DIVISLAB: 315.77
Divi's Laboratories's Days Inventory
increased
from Mar. 2025 (301.00) to Mar. 2026 (322.43).
It might indicate that Divi's Laboratories's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Divi's Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Divi's Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.40.
Divi's Laboratories (NSE:DIVISLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Divi's Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Divi's Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Divi's Laboratories Days Inventory Related Terms
Divi's Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Divi's Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Divi's Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Divi's Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Divi's Laboratories (NSE:DIVISLAB) has a Days Inventory of 322.43 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Divi's Laboratories and its competitors. This is near median its historical median of 302.56. Over the past decade, Divi's Laboratories' Days Inventory has ranged from 287.94 to 345.24. According to the industry distribution chart, Divi's Laboratories ranks #787 out of 916 companies in the Drug Manufacturers industry, placing it in the top 85.9%.
Is Divi's Laboratories' Days Inventory too high?
Divi's Laboratories' current Days Inventory of 322.43 is near median its 10-year median of 302.56. Over the past 10 years, this metric has ranged from a low of 287.94 to a high of 345.24. The Drug Manufacturers industry median Days Inventory is 164.43. Divi's Laboratories' value of 322.43 is 96.1% above this industry median. Based on the distribution chart, Divi's Laboratories ranks #787 out of 916 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Divi's Laboratories ranks #787 out of 916 companies for Days Inventory. This places Divi's Laboratories in the lower half of its industry. The industry median Days Inventory is 164.43. Divi's Laboratories' value of 322.43 is 96.1% above this benchmark. Historically, Divi's Laboratories' own Days Inventory has ranged from 287.94 to 345.24 over the past decade. While the company's 10-year median is 302.56 vs. the industry median of 164.43, Divi's Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Divi's Laboratories's current Days Inventory of 322.43 is 96.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Divi's Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Divi's Laboratories's current Days Inventory is 322.43, which is near median its own 10-year median of 302.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,732.51, compared to a current price of ₹6,713.50 — trading 0.3% below its estimated fair value. The current Days Inventory is 322.43, which is near median its 10-year median of 302.56 and 96.1% above the Drug Manufacturers industry median of 164.43. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current Days Inventory is 322.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Divi's Laboratories stock appears to be undervalued.
The current stock price of ₹6,713.50 is trading 0.3% below its estimated GF Value™ of ₹6,732.51.
GuruFocus considers Divi's Laboratories to be Fairly Valued.
Key valuation signals for NSE:DIVISLAB:
Days Inventory: 322.43 (near median its 10-year median of 302.56)
GF Value™: ₹6,732.51 vs. price of ₹6,713.50 (0.3% below fair value)
Industry Position: 96.1% above the Drug Manufacturers median (#787 of 916)
No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score
Get the complete analysis for NSE:DIVISLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DIVISLAB has been successfully added to your 
